WallStreetZenWallStreetZen

NASDAQ: CVAC
Curevac Nv Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Curevac Nv earnings were $148.1M for the trailing 12 months ending Sep 30, 2025, with 23.3% growth year over year. The latest CVAC earnings report on Sep 30, 2025 announced Q3 2025 earnings of $321.4M, down 558.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CVAC reported annual earnings of $168.9M, with -158.4% growth.

CVAC past earnings growth

How has CVAC's earnings growth performed historically?

Company
23.35%
Industry
62.42%
Market
55.48%
CVAC's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CVAC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CVAC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CVAC earnings history

Current Revenue
$83.2M
Current Earnings
$151.6M
Current Profit Margin
182.1%

CVAC Return on Equity

Current Company
18.4%
Current Industry
-21.2%
Current Market
36.2%
CVAC's Return on Equity (18.4%)... subscribe to Premium to read more.
High Return on Equity Performance

CVAC undefined

Current Company
15.3%
Current Industry
-8.7%
CVAC is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CVAC announces earnings.

CVAC undefined

Current Company
18.22%
Current Industry
-3.4%
CVAC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CVAC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CVAC$209.26M$148.07M+23.35%$0.66
INBX-$141.66M-$155.09MN/A-$11.96
ELVN-$96.57M-$97.21MN/A-$1.84
XNCR-$84.93M-$130.82MN/A-$1.73
EYPT-$203.48M-$205.75MN/A-$3.00
View Top Biotech Stocks

Curevac Nv Earnings Reports & History FAQ

What were Curevac Nv's earnings last quarter?

On CVAC's earnings call on Invalid Date, Curevac Nv (NASDAQ: CVAC) reported Q3 2025 earnings per share (EPS) of $1.42, up 15.14% year over year. Total CVAC earnings for the quarter were $321.45 million. In the same quarter last year, Curevac Nv's earnings per share (EPS) was $1.68.

If you're new to stock investing, here's how to buy Curevac Nv stock.

Is Curevac Nv profitable or losing money?

As of the last Curevac Nv earnings report, Curevac Nv is currently profitable. Curevac Nv's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $151.56 million, a 25.96% increase year over year.

What was CVAC's earnings growth in the past year?

As of Curevac Nv's earnings date in Invalid Date, Curevac Nv's earnings has grown 23.35% year over year. This is 39.08 percentage points lower than the US Biotechnology industry earnings growth rate of 62.42%. CVAC earnings in the past year totalled $148.07 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.